Speaker:

Charlie Bachtell, CEO & Director, Cresco Labs

Discussion Points:

· A reminder of why rescheduling is so relevant

· Unpacking the DOJ’s General Order of 4/23

· Why the 6/29 hearing is necessary to reach the Final Order stage

· Cresco’s exposure to med and rec

· Treasury/IRS guidance on 280e

· Implications of registering with the DEA at the federal level

· FDA oversight vs. state med regulators

· Path to custody, banking services, uplisting

#crescolabs #charliebachtell #cannabisstocks #cannabisindustry #MSOS #pablozuanic #280e #rescheduling